Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: C00-D49- Neoplasms
Conditions
Interventions
None listed
Sponsors
Nuffield Department of Surgical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: Pediatric patients with cancers
Exclusion criteria
Exclusion criteria: All other pediatric cancers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objective of the study is to determine 30- and 90-day all-cause mortality rates in children with paediatric cancers during the COVID-19 pandemic across low-, middle- and high-human development index (HDI) countries. This study will examine the factors that influenced these outcomes including tumour specific data, patient-specific demographics, and changes to health system frameworks Timepoint: 30 day outcome 90 dat all cause mortality | — |
Secondary
| Measure | Time frame |
|---|---|
| (i) 1)The changes to paediatric cancer management during the COVID-19 pandemic2)The factors that influenced these change from a health systems framework3)The infection rate of COVID-19 amongst paediatric patients 30-day post-commencement anti-cancer treatment4)The number of paediatric cancer patients who were placed under palliative care or who sought abandonment of treatment during the pandemic5)12-month all-cause mortality rates in paediatric cancer patients during the COVID-19 pandemicTimepoint: 12 month all cause mortality | — |
Countries
Ghana, India, United Kingdom
Contacts
Public ContactDhruv Nath Ghosh
Department of Pediatric Surgery APC, PGIMER, Chandigarh
Outcome results
None listed